(Lectures and Speeches) The 36th Annual Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics “Contributing to global drug development through Japan’s early-stage and exploratory clinical trials” (December 9, 2015)
date : 12/9/2015
Toshio Miyata presided over the symposium entitled, “Contributing to global drug development through Japan’s early-stage and exploratory clinical trials,” and delivered a speech titled, “Policy on early and exploratory clinical trials in Japan,” at the 36th Annual Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics.
Top Research & Recommendations Posts
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [New Research Project] Initiative for the Advancement of Dementia Research and Social System Innovation through Global Public Private Partnerships (PPP)
